Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.67%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 192.88% | -90.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 192.88% | -90.60% | |||
| Cost of Revenue | 24.63% | -84.18% | |||
| Gross Profit | 333.95% | -92.98% | |||
| SG&A Expenses | -12.58% | 41.20% | |||
| Depreciation & Amortization | -81.33% | -15.73% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.33% | -12.03% | |||
| Operating Income | 45.52% | -236.59% | |||
| Income Before Tax | -101.90% | -296.12% | |||
| Income Tax Expenses | -- | 0.00% | |||
| Earnings from Continuing Operations | -101.94% | -296.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -101.94% | -296.02% | |||
| EBIT | 45.52% | -236.59% | |||
| EBITDA | 44.97% | -230.56% | |||
| EPS Basic | -96.84% | -315.71% | |||
| Normalized Basic EPS | -57.03% | -315.13% | |||
| EPS Diluted | -96.84% | -20,700.00% | |||
| Normalized Diluted EPS | -57.03% | -25,700.00% | |||
| Average Basic Shares Outstanding | 3.07% | -8.70% | |||
| Average Diluted Shares Outstanding | 3.07% | -99.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||